Reata Pharmaceuticals Inc

VANGUARD GROUP INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

2,821,537

Value ($000)

287,684

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	287,684	0.0%	2,821,537	6/30/2023
2023 Q1	7/14/2023	250,116	0.0%	2,750,941	3/31/2023
2022 Q4	2/10/2023	102,788	0.0%	2,705,656	12/31/2022
2022 Q3	11/14/2022	66,677	0.0%	2,653,300	9/30/2022
2022 Q2	8/12/2022	79,604	0.0%	2,619,410	6/30/2022
2022 Q1	5/13/2022	86,587	0.0%	2,643,082	3/31/2022
2021 Q4	2/14/2022	67,446	0.0%	2,557,673	12/31/2021
2021 Q3	11/12/2021	255,599	0.0%	2,540,490	9/30/2021
2021 Q2	8/13/2021	359,282	0.0%	2,538,560	6/30/2021
2021 Q1	5/14/2021	242,719	0.0%	2,434,499	3/31/2021
2020 Q4	2/12/2021	286,801	0.0%	2,320,031	12/31/2020
2020 Q3	11/16/2020	205,956	0.0%	2,114,097	9/30/2020
2020 Q2	8/14/2020	343,798	0.0%	2,203,551	6/30/2020
2020 Q1	5/15/2020	323,282	0.0%	2,239,728	3/31/2020
2019 Q4	2/14/2020	442,976	0.0%	2,166,886	12/31/2019